In patients treated with primary PCI, the incidence of death/ re-MI at Day 30 was not statistically different between the two groups [6.0% in fondaparinux group vs 4.8% in the control group; hazard ratio 1.26, 95% CI, 0.96, 1.66].
Patsientidel, kellele tehti esmane PCI, ei olnud surma/ re- MI esinemissagedus statistiliselt erinev kahe rühma vahel [6, 0% fondapariinuksi rühmas vs 4, 8% kontrollrühmas; riskimäär 1, 26, 95% CI, 0, 96, 1, 66)].